α1-antitrypsin deficiency in 26-year-old subjects: Lung, liver, and protease/protease inhibitor studies

Chest

Volumn 128, Issue 4, 2005, Pages 2076-2081

  Piitulainen, Eeva ^a   Carlson, Joyce ^a   Ohlsson, Kjell ^a   Sveger, Tomas ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Epidemiology; Liver disease; Lung disease; Neonatal screening; Neutrophil lipocalin; Protease; Protease inhibitor; 1 antitrypsin deficiency

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; CERULOPLASMIN; ELASTASE; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOCALIN; OROSOMUCOID; PROTEINASE; PROTEINASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; ONCOPROTEIN; PEPTIDE HYDROLASE; PLASMA PROTEIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ASTHMA; CHOLESTASIS; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FORCED EXPIRATORY VOLUME; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; NEUTROPHIL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SMOKING; SPIROMETRY; SYMPTOM; WHEEZING; BLOOD; LIVER; LUNG; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE-PHASE PROTEINS; ADULT; ALPHA 1-ANTITRYPSIN DEFICIENCY; BLOOD PROTEINS; HUMANS; LIVER; LIVER FUNCTION TESTS; LUNG; NEUTROPHILS; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; PROTO-ONCOGENE PROTEINS; RESPIRATORY FUNCTION TESTS;

EID: 27144481559     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.4.2076     Document Type: Article

References (39)

1. American Thoracic Society/European Respiratory Society Statement: standards for the diagnosis and management of individuals with α-1-antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168:818-900
2. Crowther DC, Belorgey D, Miranda E, et al. Practical genetics: α-1-antitrypsin deficiency and the serinopathies. Eur J Genet 2004; 12:167-172
3. Sveger T. Liver disease in α-1-antitrypsin deficiency detected by screening of 200.00 infants. N Engl J Med 1976; 294: 1316-1321
4. Sveger T, Piitulainen E, Arborelius M Jr. Lung function in adolescents with α-1-antitrypsin deficiency. Acta Paediatr 1994; 83:1170-1173
5. Piitulainen E, Sveger T. Respiratory symptoms and lung function in young adults with severe α-1-antitrysin deficiency (PiZ). Thorax 2002; 57:705-708
6. Sveger T, Eriksson S. The liver in adolescents with α-1-antitrypsin deficiency. Hepatology 1995; 22:1316-1321
7. Ferris B. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 1978; 118:1-120
8. Berglund E, Birath G, Bjure J, et al. Spirometric studies in normal subjects. Acta Med Scand 1963; 2:185-191
9. Jonsson M, Carlsson J. Computer-supported interpretation of protein profiles after capillary electrophoresis. Clin Chem 2002; 48:1084-1093
10. Sveger T, Ohlsson K, Piitulainen E. Adolescents with α-1- antitrypsin deficiency have high α-2-macroglobulin and low neutrophil lipocalin and elastase levels in plasma. Pediatr Res 1998; 44:939-941
11. Rustad P. Nordic reference interval project. Available at: www.furst.no/norip;http://www.furst.no/norip. Accessed November 15, 2004
12. Carlson J, Eriksson S. α-1-antitrypsin and other acute phase reactants in liver disease. Acta Med Scand 1980; 207:79-83
13. Boström G. Health in Sweden. National Public Health Rep 2001; 58(suppl):19-46
14. Martinez FD. Role of respiratory infection in onset of asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 1999; 29:53-58
15. Ball TM, Castro-Rodriguez JA, Griffith KA, et al. Siblings day-care attendance and the risk of asthma and wheezing during childhood. N Engl J Med 2000; 343:538-543
16. DiFranza JR, Aligne CA, Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 2004; 113:1007-1015
17. Piitulainen E, Sveger T. Effect of environmental clinical factors on lung function mid respiratory symptoms in adolescents with α-1-antitrypsin deficiency. Acta Paediatr 1998; 87:1120-1124
18. Piitulainen E, Tornling G, Eriksson S. Environmental correlates if impaired lung function in non-smokers with severe α-1-antitrypsin deficiency (PiZZ). Thorax 1998; 53:939-943
19. Mayer AS, Stoller JK, Bartelsson BB, et al. Occupational exposure risks in individuals with PiZ α-1-antitrypsin deficiency. Am J Respir Crit Care Med 2000; 162:553-558
20. Lundbäck B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998; 28(suppl):3-10
21. Eden E, Mitchell D, Mehlman B, et al. Atopy, asthma and emphysema in patients with severe α-1-antitrypsin deficiency. Am J Respir Crit Care Med 1997; 156:68-74
22. Hird MF, Greenough A, Mieli-Vergani G, et al. Hyperinflation in children with liver disease due to α-1-antitrypsin deficiency. Pediatr Pulmonol 1991; 11:212-216
23. Elzouki AN, Eriksson S. Risk of hepatobiliary disease in adults with severe α-1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma? Eur J Gastroenterol Hepatol 1996; 8:989-994
24. Sveger T. Plasma protease inhibitors in α-1-antitrypsin deficient children. Pediatr Res 1985; 19:834-835
25. Sveger T, Ohlsson K, Piitulainen E. Adolescents with α-1- antitrypsin deficiency have high α-2-macroglbulin and low neutrophil lipocalin and elastase levels in plasma. Pediatr Res 1998; 44:939-941
26. Fritz H. Proteinase inhibitors in severe inflammatory processes (septic chock and experimental endotoxaeinia): biochemical, pathophysiological and therapeutic aspects. Ciba Found Symp 1979; 75:351-379
27. Buttenschoen K, Buttenschoen DC, Berger D, et al. Endotoxemia and acute phase proteins in major abdominal surgery. Am J Surg 2001; 181:36-43
28. Khan MM, Shibuya Y, Kambara T, et al. Role of α-2-macroglobulin and bacterial elastin in guinea-pig pseudomonal septic shock. Int J Exp Pathol 1995; 76:21-28
29. Axelson L, Bergenfeldt M, Björk P, et al. Release of immunoreactive canine leukocyte elastase normally and in endotoxin shock. Scand J Clin Lab Invest 1990; 50:35-42
30. Crookston KP, Webb DJ, Wolf BB, et al. Classification of α-2-macroglobulin-cytokine interactions based on affinity of non-covalent association in solution under apparent equilibrium conditions. J Biol Chem 1994; 269:1533-1540
31. Kurdowska AK, Geiser TK, Alden SM, et al. Activity of pulmonary edema fluid interleukin-8 bound to α-2-maeroglobulin in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2002; 282:1092-1098
32. Chu CT, Howard GC, Midra UK, et al. α-2-niaeroglohulin: a sensor for proteolysis. Ann N Y Acad Sci 1994; 737:291-307
33. Johnsson WJ, Pizzo SV, Inber MJ, et al. Receptors for nialeylated proteins regulate secretion of neutral proteases by niurine macrophages. Science 1982; 218:574-576
34. Goetz DH, Holmes MA, Borregaard N, et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderphore-mediated iron acquisition. Mol Cell 2002; 10: 1033-1043
35. Ohlsson K, Tegner H. Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor. Scand J Clin Lab Invest 1976; 36:437-445
36. Sallenave JM. The role of secretory leukocyte proteinase inhibitor and elafin as alarm antiproteinases in inflammatory lung disease. Respir Res 2000; 1:87-92
37. Fryksmark U, Prellner T, Tegner H, et al. Studies on the role of antileucoprotease in respiratory tract diseases. Eur J Respir Dis 1984; 65:201-209
38. Ayad MS, Knight KR, Burdon JGW, et al. Secretory leukocyte proteinase inhibitor, α-1-antitrypsin deficieney and emphysema: preliminary study, speculation and hypothesis. Respirology 2003; 8:1440-1443
39. Hiemstra PS. Novel roles of protease inhibitors in infection and inflammation. Biochem Soc Transact 2002; 30:116-120